Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Rheumatologists (EU)

July 14, 2008
Dinosaurian problem - no easy solution for Glaxo but an interesting approach
By a GLG Expert Contributor
Analysis of: Glaxo Seeks Guidance From Health Systems (online.wsj.com)
This article  is  of interest since it  deals with the problems plaguing major drug manufacturers, which in essence can be seen as a consequence  of declining  job satisfaction and creativity  among the investigators. The fundsamental reason behinf the´difficulty ...
April 29, 2008
potential innovation within anti-CD20 therapy
By a GLG Expert Contributor
Analysis of: Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (www.pipelinereview.com)
- the next generation of SMIP technology beyond antibody therapy enters clinical trials - the value of efficacy versus safety as compared to TRU-015 and the anti-CD20 antiobodies will be of key importance if it makes sense to broaden this spectrum of second generation anti-CD20s - however, it gives...
October 23, 2007
Three obvious reasons for decreasing performance of Tracleer sales
By a GLG Expert Contributor
Analysis of: Actelion shares plunge as Tracleer disappoints (www.reuters.com)
Heavy marketing has saturated potential target patients Tolerance  problems limit the  use Competitors, sitaxentan and ambrisentan arriving and  will steal market shares

Page : 11 to 3 of 3

Analytics


Generated at 2009-01-09T13:00:20.343